CARN Study Guide 2026

A significant concern with pharmacological interventions in addiction treatment is the potential for patients to misuse the prescribed medication or develop a new dependence. This risk necessitates careful monitoring by healthcare professionals, appropriate prescribing practices, and thorough patient education. The goal is to support recovery without inadvertently creating new substance use issues.

Motivational interviewing is highly effective in addiction treatment because it is a patient-centered approach that helps individuals explore and resolve their ambivalence about change. By guiding patients to articulate their own reasons for recovery and identify discrepancies between their values and current behavior, it intrinsically builds and strengthens their motivation. This technique empowers patients to commit to and sustain sobriety on their own terms.

Disulfiram works by inhibiting the enzyme aldehyde dehydrogenase, leading to an accumulation of acetaldehyde if alcohol is consumed. This causes a severe, unpleasant reaction. Many common products, including mouthwash, cough syrups, and some topical preparations, contain alcohol and can trigger this reaction.

Pharmacological treatments address the physiological aspects of addiction, such as managing severe withdrawal symptoms and reducing intense cravings. By stabilizing these physical challenges, patients are better able to engage mentally and emotionally in behavioral therapies. This integrated approach allows them to focus on developing coping mechanisms and addressing the underlying psychological factors of their addiction.

Strong evidence shows that MAT (buprenorphine, methadone, naltrexone) combined with psychosocial treatment significantly improves retention, reduces relapse, and lowers mortality.

The AVE refers to feelings of guilt, shame, and perceived personal failure following a lapse, which can trigger a cognitive-emotional cascade leading to full relapse.